|
1
|
Binder A, Ali A, Chawla R, Aziz HA, Abbate
A and Jovin IS: Myocardial protection from ischemia-reperfusion
injury post coronary revascularization. Expert Rev Cardiovasc Ther.
13:1045–1057. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tan B, Liu L, Yang Y, Liu Q, Yang L and
Meng F: Low CPNE3 expression is associated with risk of acute
myocardial infarction: A feasible genetic marker of acute
myocardial infarction in patients with stable coronary artery
disease. Cardiol J. 26:186–193. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Katanasaka Y: Development of targeted
pharmacotherapy for cardiovascular disease. Yakugaku Zasshi.
137:1349–1353. 2017.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
4
|
Lin H, Zhang X, Liao L, Yu T, Li J, Pan H,
Liu L, Kong H, Sun L, Yan M and Yao M: CPNE3 promotes migration and
invasion in non-small cell lung cancer by interacting with RACK1
via FAK signaling activation. J Cancer. 9:4215–4222.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Willerson JT, Watson JT, Hutton I, Fixler
DE, Curry GC and Templeton GH: The influence of hypertonic mannitol
on regional myocardial blood flow during acute and chronic
myocardial ischemia in anesthetized and awake intact dogs. J Clin
Invest. 55:892–902. 1975.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qian L, Shi J, Zhang C, Lu J, Lu X, Wu K,
Yang C, Yan D, Zhang C, You Q and Liu X: Downregulation of RACK1 is
associated with cardiomyocyte apoptosis after myocardial
ischemia/reperfusion injury in adult rats. In Vitro Cell Dev Biol
Anim. 52:305–313. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bhaskar S, Stanwell P, Cordato D, Attia J
and Levi C: Reperfusion therapy in acute ischemic stroke: Dawn of a
new era? BMC Neurol. 18(8)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Ischemia/Reperfusion. Compr Physiol. 7:113–170.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Granger DN and Kvietys PR: Reperfusion
therapy-What's with the obstructed, leaky and broken capillaries?
Pathophysiology. 24:213–228. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hentia C, Rizzato A, Camporesi E, Yang Z,
Muntean DM, Săndesc D and Bosco G: An overview of protective
strategies against ischemia/reperfusion injury: The role of
hyperbaric oxygen preconditioning. Brain Behav.
8(e00959)2018.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Ma K, Qiu J, Zhou M, Yang Y and Ye X:
Cox-2 negatively affects the protective role of propofol against
hypoxia/reoxygenation induced cardiomyocytes apoptosis through
suppressing akt signaling. Biomed Res Int.
2019(7587451)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ge L, Cai Y, Ying F, Liu H, Zhang D, He Y,
Pang L, Yan D, Xu A, Ma H and Xia Z: MiR-181c-5p exacerbates
hypoxia/reoxygenation-induced cardiomyocyte apoptosis via targeting
PTPN4. Oxid Med Cell Longev. 2019(1957920)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
He F, Wu Q, Xu B, Wang X, Wu J, Huang L
and Cheng J: Suppression of Stim1 reduced intracellular calcium
concentration and attenuated hypoxia/reoxygenation induced
apoptosis in H9C2 cells. Biosci Rep. 37(BSR20171249)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shi D, Lin B, Lai J, Li K and Feng Y:
Upregulation of CPNE3 suppresses invasion, migration and
proliferation of glioblastoma cells through FAK pathway
inactivation. J Mol Histol. 52:589–596. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Carati CJ, Rambaldo S and Gannon BJ:
Changes in macromolecular permeability of microvessels in rat small
intestine after total occlusion ischemia/reperfusion. Microcirc
Endothelium Lymphatics. 4:69–86. 1988.PubMed/NCBI
|
|
17
|
Hacker TA, Diarra G, Fahl BL, Back S,
Kaufmann E and Fahl WE: Significant reduction of
ischemia-reperfusion cell death in mouse myocardial infarcts using
the immediate-acting PrC-210 ROS-scavenger. Pharmacol Res Perspect.
7(e00500)2019.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Rossello X, Hall AR, Bell RM and Yellon
DM: Characterization of the langendorff perfused isolated mouse
heart model of global ischemia-reperfusion injury: Impact of
ischemia and reperfusion length on infarct size and LDH release. J
Cardiovasc Pharmacol Ther. 21:286–295. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Goldfine AB and Shoelson SE: Therapeutic
approaches targeting inflammation for diabetes and associated
cardiovascular risk. J Clin Invest. 127:83–93. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Bonaventura A, Montecucco F and Dallegri
F: Cellular recruitment in myocardial ischaemia/reperfusion injury.
Eur J Clin Invest. 46:590–601. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Heusch G: Critical issues for the
translation of cardioprotection. Circ Res. 120:1477–1486.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hausenloy DJ and Yellon DM: Ischaemic
conditioning and reperfusion injury. Nat Rev Cardiol. 13:193–209.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jiang X, Lew KS, Chen Q, Richards AM and
Wang P: Human mesenchymal stem cell-derived exosomes reduce
ischemia/reperfusion injury by the inhibitions of apoptosis and
autophagy. Curr Pharm Des. 24:5334–5341. 2018.PubMed/NCBI View Article : Google Scholar
|
